BioRestorative Net Income From Continuing Ops from 2010 to 2024
| BRTX Stock | USD 1.46 0.01 0.68% |
Net Loss | First Reported 2016-12-31 | Previous Quarter -4 M | Current Value -1.1 M | Quarterly Volatility 4.2 M |
Check BioRestorative Therapies financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among BioRestorative Therapies' main balance sheet or income statement drivers, such as Interest Expense of 12.7 K, Selling General Administrative of 7.4 M or Depreciation And Amortization of 177.8 K, as well as many indicators such as Price To Sales Ratio of 47.82, Dividend Yield of 0.0 or PTB Ratio of 0.77. BioRestorative financial statements analysis is a perfect complement when working with BioRestorative Therapies Valuation or Volatility modules.
BioRestorative | Net Income From Continuing Ops |
Latest BioRestorative Therapies' Net Income From Continuing Ops Growth Pattern
Below is the plot of the Net Income From Continuing Ops of BioRestorative Therapies over the last few years. It is BioRestorative Therapies' Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in BioRestorative Therapies' overall financial position and show how it may be relating to other accounts over time.
| Net Income From Continuing Ops | 10 Years Trend |
|
Net Income From Continuing Ops |
| Timeline |
BioRestorative Net Income From Continuing Ops Regression Statistics
| Arithmetic Mean | (12,435,677) | |
| Coefficient Of Variation | (79.61) | |
| Mean Deviation | 6,402,963 | |
| Median | (9,444,655) | |
| Standard Deviation | 9,900,481 | |
| Sample Variance | 98T | |
| Range | 38.7M | |
| R-Value | (0.63) | |
| Mean Square Error | 63.8T | |
| R-Squared | 0.40 | |
| Significance | 0.01 | |
| Slope | (1,392,736) | |
| Total Sum of Squares | 1372.3T |
BioRestorative Net Income From Continuing Ops History
About BioRestorative Therapies Financial Statements
BioRestorative Therapies investors use historical fundamental indicators, such as BioRestorative Therapies' Net Income From Continuing Ops, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in BioRestorative Therapies. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Net Loss | -15.9 M | -16.7 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for BioRestorative Stock Analysis
When running BioRestorative Therapies' price analysis, check to measure BioRestorative Therapies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioRestorative Therapies is operating at the current time. Most of BioRestorative Therapies' value examination focuses on studying past and present price action to predict the probability of BioRestorative Therapies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioRestorative Therapies' price. Additionally, you may evaluate how the addition of BioRestorative Therapies to your portfolios can decrease your overall portfolio volatility.